Chemours Company (The) vs Ecolab Inc. — Stock Comparison
Q·Score Breakdown
4
Bearish
Overall
6.6
Neutral
Quality
Health
Growth
Valuation
Sentiment
CC
56% of 9 covering analysts have a positive rating.
⚠ currently unprofitable (-7% margin).
ECL
High-quality business with 22% return on equity and 13% profit margins.
⚠ balance sheet warrants attention.
Analyst Consensus
BUY
Target $22.67 (-18.3%)
9 analysts
BUY
Target $317.48 (+22.3%)
21 analysts
Fundamentals
CC
ECL
—
Trailing P/E
35.1×
12.1×
Forward P/E
27.1×
-6.6%
Profit Margin
12.8%
15.7%
Gross Margin
44.4%
-93.8%
ROE
22.4%
-2.1%
Revenue Growth
10.0%
—
Earnings Growth
7.8%
1.40
Beta
1.02
—
Price / Book
—
$4.2B
Market Cap
$73.3B
$9 – $28
52-Week Range
$249 – $309
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →